Condition: Peripheral Neuropathy Due to Chemotherapy · Peripheral Neuropathy, Chemotherapy-induced · Sponsor: Qinghai Red Cross Hospital
Some patients receiving taxane-based chemotherapy experience numbness, tingling, or pain in their hands and feet, known as chemotherapy-induced peripheral neuropathy (CIPN). This study aims to find out whether oral mecobalamin can prevent or reduce CIPN. Participants will be assigned to take mecobalamin or to receive no routine mecobalamin prevention during chemotherapy, and outcomes will be compared between groups.
This description comes directly from the study's public registry record.
Jiuda Zhao, Dr · 869716230893 · jiudazhao@126.com
Always discuss trial participation with your own doctor first.
| Affiliated Hospital of Qinghai University | Xining, Qinghai, China | Not Yet Recruiting |
| Qinghai Red Cross Hospital | Xining, Qinghai, China | Recruiting |
| Affiliated Cancer Hospital of Shandong First Medical University (Shandong Cancer Hospital) | Jinan, Shandong, China | Not Yet Recruiting |
| Beijing Chaoyang Sanhuan Cancer Hospital | Beijing, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07423390